Aridis Pharmaceuticals Inc Investor Update Call Transcript
Thank you for standing by. This is the conference operator. Welcome to Aridis Pharmaceuticals' investor update conference call. All participants are in a listen-only mode. The conference is being recorded. The call will be open for Q&A following management's presentation. On today's call are Aridis Pharmaceuticals' CEO, Vu Truong; and CFO, Fred Kurland.
Before we begin, I would like to remind everybody that this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, along with other statements about the future expectations, beliefs, goals, plans or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact should also be considered forward-looking statements, and forward-looking statements involve risks and uncertainties.
I would now like to turn the call over to Dr. Vu Truong, Aridis Pharmaceuticals' Chief Executive Officer. Dr. Truong, please go ahead.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |